Blood biomarkers in paediatric mild traumatic brain injury: a systematic review

Conclusion GFAP appears to be a promising blood biomarker for the prognosis and monitoring of mTBI, whereas UCH-L1 appears more promising at mTBI diagnosis. Despite this, the overall heterogeneity in assessed biomarkers, study design and measurement tools has made drawing specific conclusions challenging. Future research will require more uniform study design and methodological approaches to allow for the comparison, corroboration and validation of blood biomarkers within the context of paediatric mTBI.
Source: Neuroscience and Biobehavioral Reviews - Category: Neuroscience Source Type: research